S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
NASDAQ:RPRX

Royalty Pharma Dividend Yield, History & Payout Ratio

$39.47
+0.33 (+0.84%)
(As of 01/24/2022 04:00 PM ET)
Add
Compare
Today's Range
$37.53
$39.52
50-Day Range
$37.52
$42.48
52-Week Range
$34.86
$53.15
Volume
2.12 million shs
Average Volume
1.94 million shs
Market Capitalization
$23.97 billion
P/E Ratio
30.60
Dividend Yield
1.74%
Beta
0.98

Dividend Summary

Dividend Yield
1.72%

Annual Dividend
$0.68

Dividend Increase
Track Record
2 Years

Dividend Payout Ratio
52.71%

Next
Dividend Payment
Mar. 15

Skip Charts & View Dividend History

Dividend Payments by Month (or Quarter)

Dividend Yield Over Time


Royalty Pharma (NASDAQ:RPRX) vs. Its Competitors

TypeRoyalty PharmaFinance CompaniesNASDAQ Companies
Annual Dividend$0.68$1.34$1.08
Dividend Yield1.72%5.45%2.96%
3 Year Dividend Growth0.00%52.68%42.26%
Track Record2 years5 years5 years

Royalty Pharma (NASDAQ:RPRX) Payout Ratio Breakdown

TypePayout Ratio
Based on Trailing 12 Months of Earnings52.71%
Based on This Year's Estimates23.86%
Based on Next Year's Estimates21.45%
Based on Cashflow41.07%

Royalty Pharma (NASDAQ:RPRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/6/2022Quarterly$0.191.89%2/17/20222/18/20223/15/2022
10/18/2021quarterly$0.171.8%11/18/202111/19/202112/15/2021
7/19/2021quarterly$0.171.7%8/19/20218/20/20219/15/2021
4/15/2021Quarterly$0.171.62%5/19/20215/20/20216/15/2021
1/11/2021quarterly$0.171.3%2/18/20212/19/20213/15/2021
10/16/2020quarterly$0.151.4%11/19/202011/20/202012/15/2020
9/3/2020quarterly$0.151.47%9/14/20209/15/20209/30/2020
(Data available from 1/1/2013 forward)













Royalty Pharma (NASDAQ:RPRX) Dividend Frequently Asked Questions

What is Royalty Pharma's dividend yield?

The current dividend yield for Royalty Pharma (NASDAQ:RPRX) is 1.72%. Learn more on RPRX's dividend yield history

How much is Royalty Pharma's annual dividend?

The annual dividend for Royalty Pharma (NASDAQ:RPRX) is $0.68. Learn more on RPRX's dividend details

How often does Royalty Pharma pay dividends?

Royalty Pharma (NASDAQ:RPRX) pays quarterly dividends to shareholders.

When is Royalty Pharma's next dividend payment?

Royalty Pharma's next quarterly dividend payment of $0.19 per share will be made to shareholders on Tuesday, March 15, 2022.

When was Royalty Pharma's most recent dividend payment?

Royalty Pharma's most recent quarterly dividend payment of $0.17 per share was made to shareholders on Wednesday, December 15, 2021.

Is Royalty Pharma's dividend growing?

Over the past three years, Royalty Pharma's dividend has not grown. It has decreased by 0.00%.

What track record does Royalty Pharma have of raising its dividend?

Royalty Pharma (NASDAQ:RPRX) has increased its dividend for the past 2 consecutive years.

When did Royalty Pharma last increase or decrease its dividend?

The most recent change in Royalty Pharma's dividend was an increase of $0.02 on Thursday, January 6, 2022.

What is Royalty Pharma's dividend payout ratio?

The dividend payout ratio for RPRX is:
  • 52.71% based on the trailing year of earnings
  • 23.86% based on this year's estimates
  • 21.45% based on next year's estimates
  • 41.07% based on cash flow
This page was last updated on 1/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.